Showing results (51-60 of 129) with videos related to
Sort By:
Pageof 13
Journal of Clinical Neuromuscular Disease|December 17, 2008
A review of perioperative nerve injury to the lower extremities: part IKristen C Barner, Mark E Landau, William W CampbellASDC Journal of Dentistry for Children|March 1, 1993
The relationship between alveolar bone loss and proximal caries in children: prevalence and microbiologyE Bimstein, L Shapira, E Landau, et al.American Journal of Epidemiology|July 1, 1988
Lipids and lipoproteins in new immigrant Ethiopian Jews in IsraelA Rubinstein, E Landau, U Goldbourt, et al.Muscle & Nerve|May 10, 2005
Effect of body mass index on ulnar nerve conduction velocity, ulnar neuropathy at the elbow, and carpal tunnel syndromeMark E Landau, Kristen C Barner, William W CampbellAmerican Heart Journal|August 2, 2001
The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failureC Schalcher, G Cotter, L Reisin, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1974
Craniopagus twinsA B Todorov, K L Cohen, V Spilotro, et al.American Journal of Therapeutics|July 29, 1999
Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. The Alprostadil InvestigatorsL Reisin, A Marmor, B Rabinowitz, et al.Journal of Human Hypertension|December 1, 1999
Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patientsC Yosefy, L Linov, J R Viskoper, et al.The American Journal of Cardiology|March 15, 1997
Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study GroupM Haim, H Hod, L Reisin, et al.American Heart Journal|March 7, 1998
Adding the new calcium antagonist mibefradil to patients receiving long-term beta-blocker therapy results in improved antianginal and antiischemic efficacyA Schneeweiss, I Kobrin, V Charlon, et al.Pageof 13